Arecor Therapeutics (AREC)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

140.00p
   
  • Change Today:
      2.50p
  • 52 Week High: 270.00
  • 52 Week Low: 132.50
  • Currency: UK Pounds
  • Shares Issued: 30.63m
  • Volume: 23,983
  • Market Cap: £42.88m

AREC Overview

Arecor is a globally focused biopharmaceutical company that is targeting improving patient care by bringing innovative medicines to market through the enhancement of existing therapeutic products. By applying the Group's innovative proprietary formulation technology platform, Arestat™, the Group is developing an internal portfolio of proprietary products, as well as working with pharmaceutical and biotechnology companies to deliver enhanced reformulations of their partners' therapeutic products, supported by an extensive patent portfolio.

1 Day Chart (28-03-2024)

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -442.4% n/a
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue 17.8 n/a
Pr/Book 2.5  
Latest F'cast
Revenue 107.5% n/a
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

AREC Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-20 1.70 (3.51) (17.00)p n/a n/a n/a n/a 0.0%
31-Dec-21 1.16 (6.95) (27.00)p n/a n/a n/a n/a 0.0%
31-Dec-22 2.40 (10.54) (32.00)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Latest AREC Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

AREC Market Data

Currency UK Pounds
Share Price 140.00p
Change Today 2.50p
% Change 1.82 %
52 Week High 270.00
52 Week Low 132.50
Volume 23,983
Shares Issued 30.63m
Market Cap £42.88m

AREC Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
44.58% below the market average44.58% below the market average44.58% below the market average44.58% below the market average44.58% below the market average
25.93% above the sector average25.93% above the sector average25.93% above the sector average25.93% above the sector average25.93% above the sector average
Price Trend
73.14% below the market average73.14% below the market average73.14% below the market average73.14% below the market average73.14% below the market average
15.79% below the sector average15.79% below the sector average15.79% below the sector average15.79% below the sector average15.79% below the sector average
Income Not Available
Growth
32.96% above the market average32.96% above the market average32.96% above the market average32.96% above the market average32.96% above the market average
56.76% above the sector average56.76% above the sector average56.76% above the sector average56.76% above the sector average56.76% above the sector average

AREC Dividends

No dividends found

Trades for 28-Mar-2024

Time Volume / Share Price
16:25 228 @ 135.00p
16:14 1,800 @ 135.00p
15:17 225 @ 139.00p
14:24 230 @ 139.00p
11:19 10,000 @ 137.00p

AREC Key Personnel

CEO Sarah Jennifer Howell
CFO Susan Lowther

Top of Page